staurosporine has been researched along with g(m1) ganglioside in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berton, G; Calderazzo, F; Callegaro, L; Chieco-Bianchi, L; Panozzo, M; Saggioro, D; Sorio, C | 1 |
| Berton, G; Chieco-Bianchi, L; Saggioro, D; Sorio, C | 1 |
| Bergelson, LD; Krifuks, O; Schlesinger, M | 1 |
3 other study(ies) available for staurosporine and g(m1) ganglioside
| Article | Year |
|---|---|
Mechanism of action of the monosialoganglioside GM1 as a modulator of CD4 expression. Evidence that GM1-CD4 interaction triggers dissociation of p56lck from CD4, and CD4 internalization and degradation.
Topics: Alkaloids; Antibodies, Monoclonal; CD4 Antigens; Disulfides; Epitopes; Fluorescein-5-isothiocyanate; G(M1) Ganglioside; HeLa Cells; Humans; Kinetics; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Lymphocytes; Protein Conformation; Protein Kinase C; Protein-Tyrosine Kinases; Staurosporine; Tetradecanoylphorbol Acetate; Transfection; Tumor Cells, Cultured | 1993 |
The monosialoganglioside GM1 induces internalisation and degradation of the CD4 antigen in U937 cells: evidence for a novel mechanism of CD4 down-modulation in a p56lck-negative cell line, which is independent of protein kinase C activation.
Topics: Alkaloids; Benzophenanthridines; CD4 Antigens; Down-Regulation; Endocytosis; Enzyme Activation; G(M1) Ganglioside; Humans; In Vitro Techniques; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Phenanthridines; Protein Kinase C; Proto-Oncogene Proteins; Staurosporine; Tumor Cells, Cultured | 1993 |
The down-modulation of CD4 induced by the GM1 ganglioside is regulated by phosphatases and kinases: evidence from enzyme inhibitors and anti-CD45 antibodies.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antibodies, Monoclonal; CD4 Antigens; CD4-Positive T-Lymphocytes; Down-Regulation; Enzyme Inhibitors; G(M1) Ganglioside; Gangliosides; Genistein; Humans; In Vitro Techniques; Leukocyte Common Antigens; Lymphocyte Activation; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Phosphoprotein Phosphatases; Phytohemagglutinins; Protein Kinase Inhibitors; Staurosporine; Vanadates | 1998 |